Comparison of fluconazole pharmacokinetics in serum, aqueous humor, vitreous humor, and cerebrospinal fluid following a single dose and at steady state

Journal of Ocular Pharmacology and Therapeutics

Volumn 14, Issue 5, 1998, Pages 459-471

  Mian, Umar K ^a   Mayers, Martin ^a   Garg, Yogender ^a   Liu, Qing Feng ^b   Newcomer, Girard ^a   Madu, Christian ^c   Liu, Weiguo ^b   Louie, Arnold ^b   Miller, Michael H ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c PACE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; BLOOD BRAIN BARRIER; BLOOD EYE BARRIER; CANDIDA ALBICANS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG PENETRATION; DRUG PROTEIN BINDING; ENDOPHTHALMITIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; RABBIT; STEADY STATE; VITREOUS BODY;

EID: 0031770537     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1998.14.459     Document Type: Article

References (40)

1. Brooks, R.G. Prospective study of Candida endophthalmitis in hospitalized patients with candidemia. Arch. Internal Med. 149:2226-2228, 1989.
2. Fisher, J.F., Taylor, A.T., Clark, J., and Rao, R. Penetration of amphotericin B into the human eye. J. Infect. Diseases 147:164, 1983
3. Fromtling, R.A. Overview of medically important antifungal azole derivatives. [Review]. Clin. Microbiol. Rev. 1:187-217, 1988.
4. O'Day, D.M., Foulds, G., Williams, T.E., Robinson, R.D., Allen, R.H., and Head, W.S. Ocular uptake of fluconazole following oral administration. Arch. Ophthalmol. 108:1006-1008, 1990.
5. Lyman, C.A. and Walsh, T.J. Systemically administered antifungal agents: A review of their clinical pharmacology and therapeutic applications. Drugs 44:9-35, 1992.
6. Luttrull, J.K., Wan, W.L., Kubak, B.M., Smith, M.D., and Oster, H.A. Treatment of ocular fungal infections with oral fluconazole. Amer. J. Ophthalmol. 119:477-481, 1995.
7. Laatikainen, L., Tuominen, M., and von Dickhoff, K. Treatment of endogenous fungal endophthalmitis with systemic fluconazole with or without vitrectomy [letter]. Amer. J. Ophthalmol. 113:205-207, 1992.
8. Foulds, G., Brennan, D.R., Wajszczuk, C., et al. Fluconazole penetration into cerebrospinal fluid in humans. J. Clin. Pharmacol. 28:363-366, 1988.
9. Brammer, K.W., Farrow, P.R., and Faulkner, J.K. Pharmacokinetics and tissue penetration of fluconazole in humans. [Review]. Rev. Infect. Diseases 12 Suppl 3:S318-S326, 1990.
10. Savani, D.V., Perfect, J.R., Cobo, L.M., and Durack, D.T. Penetration of new azole compounds into the eye and efficacy in experimental Candida endophthalmitis. Antimicrob. Agents Chemother. 31:6-10, 1987.
11. Sheiner, L.B. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab. Rev. 15:153-171, 1984.
12. Mayers, M., Rush, D., Madu, A., Motyl, M., and Miller, M.H. Pharmacokinetics of amikacin and chloramphenicol in the aqueous humor of rabbits. Antimicrob. Agents Chemother. 35:1791-1798, 1991.
13. Miller, M.H., Madu, A., Samathanam, G., Rush, D., Madu, C.N., Mathisson, K., and Mayers, M. Fleroxacin pharmacokinetics in aqueous and vitreous humors determined by using complete concentration-time data from individual rabbits. Antimicrob. Agents Chemother. 36:32-38, 1992.
14. Madu, A., Cioffe, C., Mian, U., Burroughs, M., Tuomanen, E., Mayers, M., Schwartz, E., and Miller, M. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid. Antimicrob. Agents Chemother. 38:2111-2115, 1994.
15. Liu, W., Louie, A., Miller, D., Perkins, R., Liu, Q., Drusano, G., Mayers, M., and Miller, M. Comparison of three antifungal agents, alone and in combination, in treating C. Albicans endophthalmitis in rabbits. Invest. Ophthalmol. Vis. Sci. 37:S773, 1996.
16. Drusano, G.L., Liu, W., Perkins, R., Madu, A., Madu, C., Mayers, M., and Miller, M.H. Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets using IT2S, a population pharmacokinetic modeling program. Antimicrob. Agents Chemother. 39:1683-1687, 1995.
17. Kane, A., Barza, M., and Baum, J. Penetration of ocular tissues and fluids by moxalactam in rabbits with staphylococcal endophthalmitis. Antimicrob. Agents Chemother. 20:595-599, 1981.
18. Barza, M. Anatomical barriers for antimicrobial agents. [Review]. Eur. J. Clin. Microbiol. Infect. Diseases 12 Suppl 1:S31-S35, 1993.
19. Barza, M., Kane, A., and Baum, J. The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor. Invest. Ophthalmol. Vis. Sci. 22(6):720-726, 1982.
20. Dacey, R.G. and Sande, M.A. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob. Agents Chemother. 6:437-441, 1974.
21. Tucker, R.M., Williams, P.L., Arathoon, E.G., Levine, B.E., Hartstein, A.C., Hanson, L.N., and Stevens, D.A. Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis. Antimicrob. Agents Chemother. 32:369-373, 1988.
22. Jorgensen, J.H., Alexander, G.A., Graybill, J.R., and Drutz, D.J. Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob. Agents Chemother. 20:59-62, 1981.
23. Akaike, H.A. A new look at the statistical model identification. IEEE. 19:716-723, 1973.
24. Arndt, C.A., Walsh, T.J., McCully, C.L., Balis, F.M., Pizzo, P.A., and Poplack, D.G. Fluconazole penetration into cerebrospinal fluid: implications for treating fungal infections of the central nervous system. J. Infect. Diseases 157:178-180, 1988.
25. Humphrey, M.J., Jevons, S., and Tarbit, M.H. Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans. Antimicrob. Agents Chemother. 28:648-653, 1985.
26. Perfect, J.R. and Durack, D.T. Penetration of imidazoles and triazoles into cerebrospinal fluid of rabbits. J. Antimicrob. Chemother. 16:81-86, 1985.
27. Perfect, J.R., Savani, D.V., and Durack, D.T. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and Candida pyelonephritis in rabbits. Antimicrob. Agents Chemother. 29:579-583, 1986.
28. Pasko, M.T., Piscitelli, S.C., and Van Slooten, A.D. Fluconazole: a new triazole antifungal agent. [Review]. Dicp. 24:860-867, 1990.
29. Walsh, T.J., Foulds, G., and Pizzo, P.A. Pharmacokinetics and tissue penetration of fluconazole in rabbits. Antimicrob. Agents Chemother. 33:467-469, 1989.
30. DeMuria, D., Forrest, A., Rich, J., Scavone, J.M., Cohen, L.G., and Kazanjian, P.H. Pharmacokinetics and bioavailability of fluconazole in patients with AIDS. Antimicrob. Agents Chemother. 37:2187-2192, 1993.
31. Foulds, G., Wajszczuk, C., Weidler, D.J., Garg, D.J., and Gibson, P. Steady state parenteral kinetics of fluconazole in man. Ann. NY Acad. Sci. 544:427-430, 1988.
32. Brammer, K.W. and Tarbit, M.H. A review of the pharmacokinetics of fluconazole (UK49858) in laboratory animals and man. In Recent trends in the discovery, development and evolution of antifungal agents, Formatting RA, ed. JR Pros Science Publishers, SA, Barcelona 1987, pp. 141-149.
33. Chin, T., Fong, I.W., and Vandenbroucke, A. Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. Pharmacotherapy 10:305-307, 1990.
34. Maurice, D.M. Injections of drugs into the vitreous body. In Symposium on ocular therapy, Leopold, I. and Burns, R., ed. Wiley, London, 1976, pp. 59-72.
35. Borne, M.J., Elliott, J.H., and O'Day, D.M. Ocular fluconazole treatment of Candida parapsilosis endophthalmitis after failed intravitreal amphotericin B [letter]. Arch. Ophthalmol. 111:1326-1327, 1993.
36. Filler, S.G., Crislip, M.A., Mayer, C.L., and Edwards, J.E., Jr. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits. Antimicrob. Agents Chemother. 35:288-292, 1991.
37. Park, S.S., D'Amico, D.J., Paton, B., and Baker, A.S. Treatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole. Antimicrob. Agents Chemother. 39:958-963, 1995.
38. Van't Wout, J.W., Mattie, H., and van Furth, R. A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. J. Antimicrob. Chemother. 21:665-672, 1988.
39. Robinson, P.A., Knirsch, A.K., and Joseph, J.A. Fluconazole for life-threatening fungal infections in patients who cannot be treated with conventional antifungal agents. Rev. Infect. Diseases. 12 Suppl 3:S349-S363, 1993.
40. Louie, A., Liu, W., Miller, D., and Miller, M.H. Comparison of fluconazole, amphotericin-B, 5-fluorocytosine and the combination of fluconazole and 5FC for the treatment of Candida albicans endocarditis, endophthalmitis, and renal disease. Abstract B48. 36th Intersci. Conf. Antimicrob. Agents Chemother. 1996.